Hepatitis Monthly

Published by: Kowsar

The Efficacy and Side Effects of Therapy with Peginterferon Alpha-2 a (PEGASYS) Combined with Ribavirin in Chronic Hepatitis C Patients: an open label Clinical Trial

Nasser Ebrahimi Daryani 1 , * , Babak Haghpanah 2 , Ali Reza Sayyah 2 , Ali Asad Hashtroudi 2 , Mohammad Bashashati 2 , Parisa Poursamimi 2 and Mehri Nikbin 2
Authors Information
1 Tehran University of Medical Sciences, Imam Khomeini Hospital & Study Group of Interferon in Iran (SG.IFN.IR), nebrahim@sina.tums.ac.ir, Tehran, IR.Iran
2 Tehran University of Medical Sciences, Imam Khomeini Hospital, Tehran, IR.Iran
Article information
  • Hepatitis Monthly: , 4 (7); 71-74
  • Article Type: Research Article

To Cite: Daryani N, Haghpanah B, Sayyah A, Hashtroudi A, Bashashati M, et al. The Efficacy and Side Effects of Therapy with Peginterferon Alpha-2 a (PEGASYS) Combined with Ribavirin in Chronic Hepatitis C Patients: an open label Clinical Trial, Hepat Mon. Online ahead of Print ;4(7):71-74.

Abstract
© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Full Text
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments